Zantac Cancer Expert Witness Testimony Could Take a Year

Zantac cancer trials hinge on the scientific evidence that heartburn medicine is carcinogenic

Tuesday, August 10, 2021 - Zantac cancer plaintiffs have filed lawsuits alleging that taking Zantac heartburn and acid reflux medicine causes their stomach, bladder, esophagus, and other forms of cancer. Zantac cancer victims allege that Sanofi-Aventis, the maker of Zantac and GalaxoSmithKline before them knew about ranitidine, the active ingredient in Zantac, being inherently unstable and deteriorating to form carcinogenic NDMA under conditions of higher than average heat during the drug's storage and while on retain shelves. Over 15 million heartburn sufferers were taking Zantac regularly when the FDA reluctantly recalled the medicine, exercising an abundance of caution. The FDA is not entirely convinced that ranitidine is necessarily carcinogenic because their tests of the molecule showed only slightly higher levels of NDMA than the 96 nanograms per tablet limit they set years back. Online prescription drug testing pharmacy Valisure used an NDMA testing method of heating the sample that may have caused the NDMA spike. LabManager.com wrote about the testing methods. "The recent ranitidine (Zantac) recall was prompted by the detection of N-nitrosodimethylamine (NDMA), a probable human carcinogen. Valisure, an American online pharmacy, detected extremely high levels of NDMA in ranitidine during routine testing using gas chromatography-mass spectrometry." Zantac Cancer lawyers are interviewing prospective plaintiffs that have allegedly developed cancer from regularly taking Zantac.

Anyone who wishes to follow the ongoing Zantac cancer lawsuits can keep track of the proceedings on the Florida Courts website. Of concern to United States District Judge Robin Rosenberg is examining the evidence that will be presented by scientific expert witnesses from both sides. Such an examination is expected to take 09 to 12 months after expert scientific witnesses' testimony is taken. Plaintiffs will call experts like Valisure CEO David Light. Mr. Light's firm, online prescription drug testing pharmacy Valisure first discovered alarmingly elevated levels of N-nitrosodimethylamine (NDMA) in each Zantac tablet they tested. Defense experts may include scientists at the Food and Drug Administration who have been unimpressed by the only slightly elevated levels of NDMA the agency's tests revealed. The court intends to set a schedule of bellwether trials to begin about one year after the Daubert Scientific hearings have concluded during which time Judge Rosenberg will have determined which scientific experts will be allowed to present their findings to juries, and which ones will be sent packing. On July 1, 2021, the court began selecting certain plaintiffs to represent the others in bellwether trials and will conclude by October of this year. According to The United States District Court in The Southern District of Florida, by October 1: "Plaintiff disclosures of disciplines and specializations of general causation experts, and areas of expertise relevant to each expert's general causation expert report. The parties shall meet and confer the format of these disclosures," and the same will be required of the defense by November 1, 2021. It may be assumed that the ongoing department of justice (DOJ) investigation of Sanofi for lying to government regulators about their knowledge of ranitidine will be published before the first bellwether trials are underway, giving jurors more evidence to consider.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.